Detection of Aβ plaque deposition in MR images based on pixel feature selection and class information in image level

BackgroundAmyloid β-protein (Aβ) plaque deposition is an important prevention and treatment target for Alzheimer’s disease (AD). As a noninvasive, nonradioactive and highly cost-effective clinical imaging method, magnetic resonance imaging (MRI) is the perfect imaging technology for the clinical diagnosis of AD, but it cannot display the plaque deposition directly. This paper resolves this problem based on pixel feature selection algorithms at the image level.Methods and resultsFirstly, the brain region was segmented from mouse model brain MR images. Secondly, the pixels in the segmented brain region were extracted as a feature vector (features). Thirdly, feature selection was conducted on the extracted features, and the optimal feature subset was obtained. Fourthly, the various optimal feature subsets were obtained by repeating the same processing above. Fifthly, based on the optimal feature subsets, the final optimal feature subset was obtained by voting mechanism. Finally, using the final optimal selected features, the corresponding pixels on the MR images could be found and marked to show the information about Aβ plaque deposition. The MR images and brain histological image slices of twenty-two model mice were used in the experiments. Four feature selection algorithms were used on the MR images and six kinds of classification experiments are conducted, thereby choosing a pixel feature selection algorithm for further study. The experimental results showed that by using the pixel features selected by the algorithms in this paper, the best classification accuracy between early AD and control slides could be as high as 80 %. The selected and marked MR pixels could show information of Aβ plaque deposition without missing most of the Aβ plaque deposition compared with brain histological slice images. The hit rate is over than 90 %.ConclusionsAccording to the experimental results, the proposed detection algorithm of the Aβ plaque deposition based on MR pixel feature selection algorithm is effective. The proposed algorithm can detect the information of the Aβ plaque deposition on MR images and the information can be useful for improving the classification accuracy as assistant MR biomarker. Besides, these findings firstly show the feasibility of detection of the Aβ plaque deposition on MR images and provide reference method for interested relevant researchers in public.

[1]  Ryan Chamberlain,et al.  Comparison of amyloid plaque contrast generated by T2‐weighted, T  2* ‐weighted, and susceptibility‐weighted imaging methods in transgenic mouse models of Alzheimer's disease , 2009, Magnetic resonance in medicine.

[2]  Rui Liu,et al.  Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease , 2011, Behavioural Brain Research.

[3]  Thomas Beyer,et al.  Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  Keith A. Johnson,et al.  Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging , 2013, Alzheimer's & Dementia.

[5]  Andrew King,et al.  Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. , 2009, Acta neuropathologica.

[6]  Philip Scheltens,et al.  Validation of soluble amyloid‐β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases , 2016, Journal of neurochemistry.

[7]  David A Bennett,et al.  Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With A&bgr; Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue , 2012, Alzheimer disease and associated disorders.

[8]  Ulas Bagci,et al.  A review on segmentation of positron emission tomography images , 2014, Comput. Biol. Medicine.

[9]  Juan Manuel Górriz,et al.  Principal component analysis-based techniques and supervised classification schemes for the early detection of Alzheimer's disease , 2011, Neurocomputing.

[10]  Andrea Chincarini,et al.  Medial temporal lobe high resolution magnetic resonance images for the early diagnosis of Alzheimer's disease , 2015, 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[11]  Sascha Weggen,et al.  Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X , 2015, Scientific Reports.

[12]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[13]  C. Jack,et al.  Boosting power for clinical trials using classifiers based on multiple biomarkers , 2010, Neurobiology of Aging.

[14]  P. Thompson,et al.  PET of brain amyloid and tau in mild cognitive impairment. , 2006, The New England journal of medicine.

[15]  Kaj Blennow,et al.  β-Amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer’s disease , 2002, Peptides.

[16]  Edward S. Yang,et al.  P4-007 High field MRI study of the beta amyloid and plaque deposits in the brain of APP/PS1 mice , 2006, Alzheimer's & Dementia.

[17]  Yong Fan,et al.  Detection of Alzheimer's disease using group lasso SVM-based region selection , 2015, Medical Imaging.

[18]  S. Ramakrishnan,et al.  Diffusion Tensor Based Alzheimer Image Analysis Using Region Specific Volume Features and Random Forest Classifier , 2014 .

[19]  Yongming Li,et al.  Two coding based adaptive parallel co-genetic algorithm with double agents structure , 2010, Eng. Appl. Artif. Intell..

[20]  Chokri Ben Amar,et al.  Alzheimer's disease diagnosis on structural MR images using circular harmonic functions descriptors on hippocampus and posterior cingulate cortex , 2015, Comput. Medical Imaging Graph..

[21]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[22]  H. Lester,et al.  Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease , 2005, PLoS medicine.

[23]  Qing X Yang,et al.  MRI and histological analysis of beta‐amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice , 2009, Journal of magnetic resonance imaging : JMRI.